Learn Best Practices From Your Peers At The Gross-To-Net Accounting Forum, 17-18 June 2013, Boston, MA

Date: Mar-18-2013Ensuring your Gross-to-Net calculations are accurate is a messy business, but a necessary one. In the GTN space, the pharmaceutical industry has just recently begun to open up about forecasting and accruing for liability or working interdepartmentally between the commercial and government sectors.

At IIR's Gross-to-Net Accounting Forum for Pharmaceutical Manufacturers, we know how important it is for you to be able to benchmark your systems and methodologies against best practices. For that reason, we have developed unique formats whereby our session leaders and our audience interact before and during the event to ensure your most pressing GTN questions are answered when you are in Boston.

Some of these interactive session highlights include:

Top 10 GTN Hot Topics to Benchmark Your Gross-to-Net Processes, Systems & Methodologies

This valuable benchmarking exercise focuses on GTN organization/process design, system implementation, contract analytics, performance monitoring, contract forecasting, accruals, SOP/SOX documentation and management reporting. A live, dynamic audience poll on hot topics as well as industry case studies will get you "in the know" with how your peers are getting to their calculations.

How Big Pharma Is Managing Gross-to-Net Processes

If you did not know there was a GTN Best Practices Industry Group, you do now! This session will highlight the latest best practice results, providing the attendees with guidance to take home and add to their GTN strategies. Interactive dialogue ensures no topic is left without a discussion.

Details:

June 17-18, 2013

Hyatt Harbor Side

Boston, MA

Download the event brochure for full agenda details.

This Friday, March 22nd marks your last chance to SAVE $400 off the Standard Registration Rate. To register, visit the website or call (888) 670-8200. Be sure to use priority code XP1811MNT2 when registering.
Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.